?

Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1537 publications
Global Prostate Cancer Devices Market 2015-2019 US$ 2,500.00

... vendors in the market. The vendor landscape in this report focuses on those vendors that provide access to new prostate cancer devices. Technavio's report, Global Prostate Cancer Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry ...

Jun, 2015 91 pages
Global Cancer Biosimilars Market Opportunity Outlook US$ 1,800.00

... Cancer Biosimilars Global Cancer Biosimilars Market Dynamics FDA & EMA Guidelines on Development & Marketing of Biosimilars Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase Cancer Biosimilars Clinical Pipeline: 100 Biosimilars Marketed Cancer Biosimilars Clinical Insight Marketed Cancer ...

Jun, 2015 550 pages
Global Colorectal Cancer Drugs Market 2015-2019 US$ 3,000.00

... four broad stages. Colorectal cancer can be treated using surgical, chemotherapeutic, biologic, and radiation therapies. Technavio's analysts forecast the global colorectal cancer drugs market to grow at a CAGR ... market at large, as well as the key trends that are emerging in the market. Technavio's report, Global Colorectal Cancer Drugs Market 2015-2019, has been prepared based on an in-depth market ...

Jun, 2015 125 pages
Global Cancer Vaccines Market 2015-2019 US$ 2,500.00

... global cancer vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various therapeutic and prophylactic cancer vaccines ... the market at large, as well as the key trends that are emerging in the market. Technavio's report, Global Cancer Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis ...

Jun, 2015 64 pages
Competitive Intelligence 2015: Leading Transfusion Diagnostic Testing Market Players - Strategic Assessments of Major Suppliers and Emerging Market Entrants US$ 2,450.00

... .com provides extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. The assessments include: Sales Product ...

Jun, 2015 50 pages
Competitive Intelligence 2015: Leading Tumor Marker Diagnostics Market Players - Strategic Assessments of Major Suppliers and Emerging Market Entrants US$ 2,500.00

... .com provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: Sales ...

Jun, 2015 80 pages
2015 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals,... US$ 9,800.00

... . The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the US Cancer Diagnostics Industry ... and the rapid market expansion. US Market Overview Five-year test volume and sales projections. Comprehensive market segmentation analysis, including review of the market dynamics, structure ...

Jun, 2015 620 pages
2015 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals and... US$ 6,700.00

... . The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the Spanish Cancer Diagnostics ... the rapid market expansion. Spanish Market Overview Five-year test volume and sales projections. Comprehensive market segmentation analysis, including review of the market dynamics, structure ...

Jun, 2015 565 pages
2015 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals and... US$ 6,700.00

... is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in Spain. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...

Jun, 2015 565 pages
2015 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals and... US$ 8,800.00

... is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in Japan. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...

Jun, 2015 590 pages
2015 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals and... US$ 6,700.00

... is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in Italy. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...

Jun, 2015 570 pages
2015 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals,... US$ 6,700.00

... is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in Germany. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...

Jun, 2015 585 pages
2015 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals and... US$ 6,700.00

... is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in France. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...

Jun, 2015 585 pages
2015 New Frontiers in the US Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape US$ 9,800.00

... , supplier shares) $6,400. '2015 New Frontiers in the U.S. Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape' is VPGMarketResearch's new study of the major business ... spectroscopy. Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic ...

Jun, 2015 620 pages
2015 New Frontiers in the UK Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape US$ 6,800.00

... , supplier shares) $4,350. '2015 New Frontiers in the UK Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape' is VPGMarketResearch's new study of the major business ... spectroscopy. Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic ...

Jun, 2015 565 pages
2015 New Frontiers in the Spanish Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape US$ 6,800.00

... supplier shares) $4,350. '2015 New Frontiers in the Spanish Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape' is VPGMarketResearch's new study of the ... malignancy assays and the rapid market expansion worldwide. Spain Market Overview Five-year test volume and sales ...

Jun, 2015 565 pages
2015 New Frontiers in the Japanese Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape US$ 7,600.00

... supplier shares) $4,900. '2015 New Frontiers in the Japanese Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape' is VPGMarketResearch's new study of the ... malignancy assays and the rapid market expansion worldwide. Japan Market Overview Five-year test volume and sales ...

Jun, 2015 590 pages
2015 New Frontiers in the Italian Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape US$ 6,800.00

... supplier shares) $4,350. '2015 New Frontiers in the Italian Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape' is VPGMarketResearch's new study of the ... malignancy assays and the rapid market expansion worldwide. Italy Market Overview Five-year test volume and sales ...

Jun, 2015 570 pages
2015 New Frontiers in the German Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape US$ 6,800.00

... supplier shares) $4,350. '2015 New Frontiers in the German Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape' is VPGMarketResearch's new study of the ... malignancy assays and the rapid market expansion worldwide. Germany Market Overview Five-year test volume and sales ...

Jun, 2015 585 pages
2015 New Frontiers in the French Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape US$ 6,800.00

... supplier shares) $4,350. '2015 New Frontiers in the French Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape' is VPGMarket's new study of the major ... for malignancy assays and the rapid market expansion worldwide. France Market Overview Five-year test volume and sales ...

Jun, 2015 585 pages
2015 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals,... US$ 19,700.00

... available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in Europe. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...

Jun, 2015 820 pages
2015 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals,... US$ 34,500.00

... report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the Global Cancer Diagnostics ... , UK, USA WORLDWIDE MARKET OVERVIEW Five-year test volume and sales projections by country. Comprehensive market segmentation analysis, including review of the market dynamics, structure, size ...

Jun, 2015 1200 pages
2015 Tumor Markers: Unlocking the Mistery of the Genetic Basis of Cancer--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence US$ 24,500.00

... Reviews current and emerging tumor markers Analyzes applications of emerging diagnostic technologies Forecasts sales of major tumor markers by country and market segment ... approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the ...

Jun, 2015 1200 pages
2015 Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence US$ 24,500.00

... , sales forecasts, supplier shares) $15,900. '2015 Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence' is VPGMarketResearch's new study ... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. RATIONALE The cancer diagnostics market is on the ...

Jun, 2015 1200 pages
2015 New Frontiers in the European Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape US$ 19,700.00

... , supplier shares) $12,800. '2015 New Frontiers in the European Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape' is VPGMarketResearch's new study of the major ... spectroscopy. Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic ...

Jun, 2015 820 pages
2015 New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape US$ 34,750.00

... ) $21,100. '2015 New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape' is VPGMarketResearch's new study of the major business opportunities emerging in the global cancer diagnostics ... spectroscopy. Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic assessments ...

Jun, 2015 1200 pages
Cancer Immunomodulators Market & Pipeline Insight 2020 US$ 2,000.00

... Immunomodulators Cancer Immunomodulators Mechanism Cancer Immunomodulators Clinical Pipeline By Company, Indication & Phase Cancer Immunomodulators Clinical Pipeline: 747 Cancer Immunomodulators Drugs Majority Cancer Immunomodulators in Preclinical Phase: 300 Marketed Cancer Immunomodulators ...

Jun, 2015 1000 pages
Salivary Gland Cancer - Pipeline Review, H1 2015 US$ 2,000.00

... Salivary Gland Cancer - Pipeline Review, H1 2015’, provides an overview of the Salivary Gland Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Salivary Gland Cancer, complete with comparative analysis at various stages, therapeutics assessment ...

May, 2015 53 pages
Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer,... US$ 4,650.00

... growth of the cancer diagnostics market. The instrument-based cancer diagnostics segment accounted for the largest share of the global the cancer diagnostics market, by technology, while breast cancer accounted for the largest share of the cancer diagnostics applications market ...

Jun, 2015 181 pages
Global Cancer Immunotherapy Market Outlook 2020 US$ 3,600.00

... Monoclonal Antibodies, Vaccines 'Global Cancer Immunotherapy Market Outlook 2020' Report Highlight: Introduction & Classification of Cancer Immunotherapy Global Cancer Immunotherapy Pipeline by Company, Indication & Phase Marketed Cancer Immunotherapies ...

Jun, 2015 2600 pages
Global Melanoma Therapeutics Industry 2015 Market Research Report US$ 2,850.00

2015 Global Melanoma Therapeutics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Melanoma Therapeutics industry, focusing on the main ... with: 1.) basic information; 2.) the Asia Melanoma Therapeutics industry; 3.) the North American Melanoma Therapeutics industry; 4.) the European Melanoma Therapeutics industry; 5.) market entry and investment feasibility ...

May, 2015 170 pages
EpiCast Report: Prostate Cancer - Epidemiology Forecast to 2023 US$ 3,995.00

... prevalent cases (8.98%). Scope The Prostate Cancer EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for prostate cancer in the nine major markets ... bone metastases status. The prostate cancer epidemiology report is written and developed by Masters and PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent ...

May, 2015 51 pages
EpiCast Report: Melanoma - Epidemiology Forecast to 2023 US$ 3,995.00

... 2012 to assess the validity of GlobalData’s epidemiological forecast and found the two to be in accordance. Scope The Melanoma EpiCast Report provides an overview of the risk factors ... and c-KIT) in these markets. The melanoma epidemiology report is written and developed by Masters and PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent ...

May, 2015 51 pages
Competitive Intelligence 2015: Leading Cancer Diagnostics Market Players - Strategic Assessments of Major Suppliers and Emerging Market Entrants US$ 2,500.00

... report from Venture Planning Group provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios ...

May, 2015 80 pages
Papillary Thyroid Cancer - Pipeline Review, H1 2015 US$ 2,000.00

... Thyroid Cancer - Pipeline Review, H1 2015’, provides an overview of the Papillary Thyroid Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Papillary Thyroid Cancer, complete with comparative analysis at various stages, therapeutics assessment ...

Apr, 2015 105 pages
Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 US$ 1,800.00

... Cancer Monoclonal Antibodies Pipeline: 62 mAb Majority Breast Cancer Monoclonal Antibodies in Preclinical Phase: 17 mAb Marketed Breast Cancer Monoclonal Antibodies: 6 mAb Marketed Breast Cancer Monoclonal Antibodies Clinical Insight Bevacizumab (Avastin) Pertuzumab (Omnitarg, Perjeta) Trastuzumab (Herceptin ...

May, 2015 190 pages
Oxaliplatin Anti-Cancer Global Market and Forecast Research 2015 US$ 2,600.00

... Note: This report will be updated to last month. Oxaliplatin Anti-Cancer is an active pharmaceutical ingredient (API) for the pharmaceutical industry. API ( ... , Asia and Europe) Oxaliplatin Anti-Cancer industry, focusing on the capacity and production volumes, manufacturers, prices, import & export, market forecast and consumers, including ...

May, 2015 65 pages
Cisplatin Anti-Cancer Global Market and Forecast Research 2015 US$ 2,600.00

... Note: This report will be updated to last month. Cisplatin Anti-Cancer is an active pharmaceutical ingredient (API) for the pharmaceutical industry. API ( ... , Asia and Europe) Cisplatin Anti-Cancer industry, focusing on the capacity and production volumes, manufacturers, prices, import & export, market forecast and consumers, including ...

May, 2015 65 pages
Carmustine Anti-Cancer Global Market and Forecast Research 2015 US$ 2,600.00

... Note: This report will be updated to last month. Carmustine Anti-Cancer is an active pharmaceutical ingredient (API) for the pharmaceutical industry. API ( ... , Asia and Europe) Carmustine Anti-Cancer industry, focusing on the capacity and production volumes, manufacturers, prices, import & export, market forecast and consumers, including ...

May, 2015 65 pages
Carboplatin Anti-Cancer Global Market and Forecast Research 2015 US$ 2,600.00

... Note: This report will be updated to last month. Carboplatin Anti-Cancer is an active pharmaceutical ingredient (API) for the pharmaceutical industry. API ( ... , Asia and Europe) Carboplatin Anti-Cancer industry, focusing on the capacity and production volumes, manufacturers, prices, import & export, market forecast and consumers, including ...

May, 2015 65 pages
Ureter Cancer - Pipeline Review, H1 2015 US$ 2,000.00

Ureter Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Ureter Cancer - Pipeline Review, H1 2015’, provides an overview of the Ureter Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ureter Cancer ...

Apr, 2015 69 pages
Pheochromocytoma - Pipeline Review, H1 2015 US$ 2,000.00

... Pheochromocytoma - Pipeline Review, H1 2015’, provides an overview of the Pheochromocytoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pheochromocytoma, complete with comparative analysis at various stages, therapeutics assessment ...

Apr, 2015 64 pages
Pancreatic Endocrine Tumor - Pipeline Review, H1 2015 US$ 2,000.00

... Tumor - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Pancreatic Endocrine Tumor - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Endocrine Tumor’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pancreatic Endocrine Tumor ...

Apr, 2015 59 pages
Vulvar Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Vulvar Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Vulvar Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Uterine Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Uterine Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Uterine Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Insights, 2015 US$ 1,250.00

... Cell Carcinoma) Landscape across the globe The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology ... Cell Carcinoma) Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine. Track your ...

May, 2015 60 pages
Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Insights, 2015 US$ 1,250.00

... Cell Cancer) Landscape across the globe The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology ... Cell Cancer) Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine. Track your ...

May, 2015 60 pages
Thyroid Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Thyroid Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Thyroid Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Thymus Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Thymus Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Thymus Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Testicular Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Testicular Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Testicular Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
1 2 3 4 5 >
Skip to top